Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids.
about
Lysophosphatidic acid, LPA: a bad boy becomes goodAutotaxin-LPA receptor axis in the pathogenesis of lung diseasesSphingolipids in human synovial fluid--a lipidomic studyQuantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule.Cyclic phosphatidic acid is produced by autotaxin in blood.Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model.Pre-emptive morphine treatment abolishes nerve injury-induced lysophospholipid synthesis in mass spectrometrical analysis.Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind HydeTherapeutic efficacy of lysophosphatidylcholine in severe infections caused by Acinetobacter baumannii.Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators.Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activityCyclic phosphatidic acid - a unique bioactive phospholipid.Therapeutic potential of autotaxin/lysophospholipase d inhibitors.Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation.Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumorsLysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.Biomarker candidates for the detection of an infectious etiology of febrile neutropenia.Lysophosphatidic acid protection against apoptosis in the human pre-B-cell line Nalm-6.Signal transduction mechanisms involved in the proliferation of C6 glioma cells induced by lysophosphatidic acid.Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor.Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.Lysophosphatidic acid differentially regulates axonal mRNA translation through 5'UTR elementsTheophylline and cAMP inhibit lysophosphatidic acid-induced hyperresponsiveness of bovine tracheal smooth muscle cells.Attenuation by cyclic phosphatidic acid of peritoneal metastasis of azoxymethane-induced intestinal cancers in Wistar rats.Sequential activation of RhoA and FAK/paxillin leads to ATP release and actin reorganization in human endothelium.Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources.The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a signal peptide.
P2860
Q24797056-5B1CED26-7443-46E5-BD3F-01A820BC642CQ26862679-0A9E3DEA-1A65-47AB-8342-80716AB064F3Q28397810-72C0B6EF-7CB7-407F-B134-77C12F112C0DQ33206022-AFD7D13E-2CAC-4F03-93DC-FFE44A1C195EQ33249980-9731935C-F6B9-4D74-9FDB-F7FABC1DAC50Q33759458-25A7AE12-0DBA-4705-94DF-6B065F1E1AFAQ33889889-CD8D0B46-B0B7-4547-94F8-8DD29D184E29Q35264010-43FBF361-C63B-4927-B622-10C17B6EA2B1Q35746123-DD04E592-6A40-4D26-8528-0DD0E10D9F74Q35839006-3366F9C7-38D8-4F3E-8DC6-4014B3F7A858Q36861053-A447E26D-CFF7-49F8-A44C-8861F9733D96Q36947041-462979AC-DAA2-4D7B-A34F-53EF085B3987Q37049044-7EAF84D6-631D-43B3-96CD-E539438011FCQ37137675-B668A4D6-D638-4814-960D-58E385F8BD87Q37139302-F0818DF4-A760-4C8E-8D4D-F9810721A703Q37304404-46FD233D-2C2D-452A-8464-15077C7E11FDQ37372468-58F15888-54FB-4EB8-B3C7-1558F0EE28B5Q37433301-EFEBF930-1119-42CD-A74E-7BE13C983D9BQ40143144-6B30E3C7-83B2-4769-8DA0-56BEB1040EFCQ40147708-A2830D35-F78B-4A5E-ADC2-13D25CE75635Q40370649-D7FB4457-3C0F-4A1A-A363-C43A94943DC6Q40457161-E06E052D-A68D-4751-90B2-F765B860BA49Q41887380-C9828BF2-BF14-4661-A38C-9579BB94EAFFQ42154463-72A4F3FB-A35C-4BD3-895F-DD0A478C250EQ44392761-35136B47-A75B-489A-BF7B-16842A6A63C5Q44834242-0FF11078-3449-4ACB-8D8D-C8C3402B7E52Q44904878-C858D23F-4AAE-4926-A0DD-05A71D1BD375Q45247894-101B3240-FA66-45D2-B096-4458B5B3186BQ46911092-CD7E00E2-94C5-4AE9-9900-FBFA52A1D9EE
P2860
Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Physiological and pathophysiol ...... hospholipase D in body fluids.
@ast
Physiological and pathophysiol ...... hospholipase D in body fluids.
@en
Physiological and pathophysiol ...... hospholipase D in body fluids.
@nl
type
label
Physiological and pathophysiol ...... hospholipase D in body fluids.
@ast
Physiological and pathophysiol ...... hospholipase D in body fluids.
@en
Physiological and pathophysiol ...... hospholipase D in body fluids.
@nl
prefLabel
Physiological and pathophysiol ...... hospholipase D in body fluids.
@ast
Physiological and pathophysiol ...... hospholipase D in body fluids.
@en
Physiological and pathophysiol ...... hospholipase D in body fluids.
@nl
P1476
Physiological and pathophysiol ...... hospholipase D in body fluids.
@en
P2093
Akira Tokumura
P356
10.1016/S1388-1981(02)00133-6
P407
P577
2002-05-01T00:00:00Z